Synthorx, Inc.. (THOR) NASDAQ

$67.99 0 (0.00%)

Market Cap: $2.20B

As of 01/22/20 12:00 AM EST. Market closed.

(THOR)

Synthorx, Inc.. (THOR)
NASDAQ

$67.99
0 (0.00%)

Market Cap: $2.20B

As of 01/22/20 12:00 AM EST. Market closed.

Synthorx, Inc. focuses on prolonging and improving lives of cancer and autoimmune disorder patients. Its product pipeline is comprised of THOR-707, IL-2 Synthorin, IL-10 Synthorin, and IL-15 Synthorin. The company was founded by Floyd E. Romesberg and Court R. Turner in 2014 and is headquartered in La Jolla, ... read more

Synthorx, Inc. focuses on prolonging and improving lives of cancer and autoimmune disorder patients. Its product pipeline is comprised of THOR-707, IL-2 Synthorin, IL-10 Synthorin, and IL-15 Synthorin. The company was founded by Floyd E. Romesberg and Court R. Turner in 2014 and is headquartered in La Jolla, CA. read less

COMPANY PROFILE
Sector
Health Technology
Industry
Biotechnology
CEO Compensation (Base)
$430,125
CEO Compensation (Total)
$5.21M
URL
Address
.
Sector
Health Technology
Industry
Biotechnology
Full Time Employees
38
CEO Compensation (Base)
$430,125
CEO Compensation (Total)
$5.21M
Address
.
PRICE CHART FOR SYNTHORX, INC.
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$0
Previous Close
$67.99
Days Range
$0 - $0
52 week range
$11.05 - $71.90
Volume
0
Avg. Volume (30 days)
502,510
Market Cap
$2.20B
Dividend Yield
0.00%
P/E
-
Shares Outstanding
32,338,000
Open
$0
Previous Close
$67.99
Days Range
$0 - $0
52 week range
$11.05 - $71.90
Volume
0
Avg. Volume (30 days)
502,510
Market Cap
$2.20B
Dividend Yield
0.00%
P/E
-
Shares Outstanding
32,338,000

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SYNTHORX, INC.
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Thompson Peter A.DirectorJan 23, 2020 Option Exercise$68.005,316,355361,512,1400Jan 24, 2020, 06:44 PM
Shawver LauraPresident and CEOJan 23, 2020 Option Exercise$68.00220,59515,000,4600Jan 24, 2020, 06:41 PM
Shawver LauraPresident and CEOJan 23, 2020 Option Exercise$68.0025,0001,700,0000Jan 24, 2020, 06:41 PM
Shah PratikDirectorJan 23, 2020 Option Exercise$68.0062,4124,244,0160Jan 24, 2020, 06:38 PM
Reardon TigheActing Chief Financial OfficerJan 23, 2020 Option Exercise$68.001,682,086114,381,8480Jan 24, 2020, 06:36 PM
Reardon TigheActing Chief Financial OfficerJan 23, 2020 Option Exercise$68.0043,6882,970,7840Jan 24, 2020, 06:36 PM
Milla MarcosChief Scientific OfficerJan 23, 2020 Option Exercise$68.0063,9894,351,2520Jan 24, 2020, 06:31 PM
Lichter JayDirectorJan 23, 2020 Option Exercise$68.00448,56730,502,5560Jan 24, 2020, 06:28 PM
Lichter JayDirectorJan 23, 2020 Option Exercise$68.00150,00010,200,0000Jan 24, 2020, 06:28 PM
Lichter JayDirectorJan 23, 2020 Option Exercise$68.001,682,086114,381,8480Jan 24, 2020, 06:28 PM
Leveque JosephChief Medical OfficerJan 23, 2020 Option Exercise$68.00316,16421,499,1520Jan 24, 2020, 06:26 PM
Kolchinsky PeterDirectorJan 23, 2020 Option Exercise$68.009,724,598661,272,6640Jan 24, 2020, 06:23 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerJan 23, 2020 Option Exercise$68.009,724,598661,272,6640Jan 24, 2020, 05:53 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerJan 23, 2020 Option Exercise$68.009,724,598661,272,6640Jan 24, 2020, 05:11 PM
Leveque JosephChief Medical OfficerDec 30, 2019 Option Exercise$70.6345,0193,179,692313,891Jan 02, 2020, 04:43 PM
Leveque JosephChief Medical OfficerDec 30, 2019 Option Exercise$11.0075,000825,000358,910Jan 02, 2020, 04:43 PM
Milla MarcosChief Scientific OfficerDec 30, 2019 Option Exercise$70.6352,0113,673,53763,989Jan 02, 2020, 04:41 PM
Milla MarcosChief Scientific OfficerDec 30, 2019 Option Exercise$0.6398,00061,740116,000Jan 02, 2020, 04:41 PM
Shawver LauraPresident and CEODec 30, 2019 Option Exercise$70.63210,01014,833,006296,301Jan 02, 2020, 04:39 PM
Shawver LauraPresident and CEODec 30, 2019 Option Exercise$4.02379,4531,525,319506,311Jan 02, 2020, 04:39 PM
Shawver LauraPresident and CEOJan 24, 2019 Option Exercise$0.6325,00015,75025,000Jan 25, 2019, 04:33 PM
Thompson Peter A.DirectorDec 11, 2018 Buy$11.001,363,63614,999,9965,316,355Dec 13, 2018, 06:37 PM
Reardon TigheActing Chief Financial OfficerDec 11, 2018 Buy$11.00545,4556,000,0051,682,086Dec 13, 2018, 06:36 PM
Lichter JayDirectorDec 11, 2018 Buy$11.00545,4556,000,0051,682,086Dec 13, 2018, 06:35 PM
ORBIMED ADVISORS LLCDirectorDec 11, 2018 Buy$11.001,363,63614,999,9961,363,636Dec 13, 2018, 06:33 PM
Kolchinsky PeterDirectorDec 11, 2018 Buy$11.004,545,45550,000,0059,724,598Dec 13, 2018, 06:31 PM
Avalon Ventures X, L.P.10% OwnerDec 11, 2018 Buy$11.00545,4556,000,0051,682,086Dec 13, 2018, 06:30 PM
RA CAPITAL MANAGEMENT, LLC10% OwnerDec 11, 2018 Buy$11.004,545,45550,000,0059,724,598Dec 13, 2018, 06:30 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Thompson Peter A.Director01/23/2020361,512,140
Shawver LauraPresident and CEO01/23/202015,000,460
Shawver LauraPresident and CEO01/23/20201,700,000
Shah PratikDirector01/23/20204,244,016
Reardon TigheActing Chief Financial Officer01/23/2020114,381,848
Reardon TigheActing Chief Financial Officer01/23/20202,970,784
Milla MarcosChief Scientific Officer01/23/20204,351,252
Lichter JayDirector01/23/202030,502,556
Lichter JayDirector01/23/202010,200,000
Lichter JayDirector01/23/2020114,381,848
Leveque JosephChief Medical Officer01/23/202021,499,152
Kolchinsky PeterDirector01/23/2020661,272,664
RA CAPITAL MANAGEMENT, L.P.10% Owner01/23/2020661,272,664
RA CAPITAL MANAGEMENT, L.P.10% Owner01/23/2020661,272,664
Leveque JosephChief Medical Officer12/30/20193,179,692
Leveque JosephChief Medical Officer12/30/2019825,000
Milla MarcosChief Scientific Officer12/30/20193,673,537
Milla MarcosChief Scientific Officer12/30/201961,740
Shawver LauraPresident and CEO12/30/201914,833,006
Shawver LauraPresident and CEO12/30/20191,525,319
Shawver LauraPresident and CEO01/24/201915,750
Thompson Peter A.Director12/11/201814,999,996
Reardon TigheActing Chief Financial Officer12/11/20186,000,005
Lichter JayDirector12/11/20186,000,005
ORBIMED ADVISORS LLCDirector12/11/201814,999,996
Kolchinsky PeterDirector12/11/201850,000,005
Avalon Ventures X, L.P.10% Owner12/11/20186,000,005
RA CAPITAL MANAGEMENT, LLC10% Owner12/11/201850,000,005
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR SYNTHORX, INC.
STOCK BUYBACKS FOR SYNTHORX, INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2019
06/30/2019
0.31%
1Q

Period of Report: 09/30/2019

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2019
0.31%
1Q